D-serine AudRem: R33 Phase

Clinical trial NCT05046353 · SUSPENDED

Trial details

NCT number: NCT05046353
Sponsor: New York State Psychiatric Institute
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizo Affective Disorder

Start date: 2022-12-01
Primary completion: 2027-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.